Brandt KD. Effects of nonsteroidal anti-inflammatory drugs on chondrocyte metabolism in vitro and in vivo.
Am J Med. 1987;83:29 - 34.
Brooks PM, Potter SR, Buchanan WW. NSAID and osteoarthritis - help or hindrance [editorial].
J Rheumatol. 1982;9:3 - 5.
Shield MJ. Anti-inflammatory drugs and their effects on cartilage synthesis and renal function.
Eur J Rheumatol Inflamm. 1993;13:7 - 16.
Palmoski MJ, Brandt KD. Effects of some nonsteroidal antiinflammatory drugs on proteoglycan metabolism and organization in canine articular cartilage.
Arthritis Rheum. 1980;23:1010 - 1020.
Rashad S, Revell P, Hemingway A, et al. Effect of nonsteroidal anti-inflammatory drugs on the course of osteoarthritis.
Lancet. 1989;2:519 - 522.
Lippiello L, Woodward J, Karpman R, et al. In vivo chondroprotection and metabolic synergy of glucosamine and chondroitin sulfate.
Clin Orthop.
2000;(381):229 - 240.
Lippiello L, Karpman RR, Hammad T. Synergistic effect of glucosamine HCL and chondroitin sulfate on in vitro proteoglycan synthesis by bovine chondrocytes. Presented at: American Academy of Orthopaedic Surgeons 67th Annual Meeting; March 15 - 19, 2000.
Adebowale AO, Cox DS, Liang Z, et al. Analysis of glucosamine and chondroitin sulfate content in marketed products and the Caco-2 permeability of chondroitin sulfate raw materials.
J Am Nutraceutical Assoc.
2000;3:37 - 44.
Bucsi L, Poor G. Efficacy and tolerability of oral chondroitin sulfate as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) in the treatment of knee osteoarthritis.
Osteoarthritis Cartilage. 1998;6(suppl A):31 - 36.
Conrozier T. Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6) [translated from French].
Presse Med. 1998;27:1862 - 1865.
Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study.
Osteoarthritis Cartilage. 1998;6(suppl A):39 - 46.
Bourgeois P, Chales G, Dehais J, et al. Efficacy and tolerability of chondroitin sulfate 1200 mg/day vs chondroitin sulfate 3 x 400 mg/day vs placebo.
Osteoarthritis Cartilage. 1998;6(suppl A):25 - 30.
Mazieres B, Loyau G, Menkes CJ, et al. Chondroitin sulfate in the treatment of gonarthrosis and coxarthrosis. 5-months result of a multicenter double-blind controlled prospective study using placebo [in French; English abstract].
Rev Rhum Mal Osteoartic.
1992;59:466 - 472.
Das A Jr, Hammad TA. Efficacy of a combination of FCHG49 glucosamine hydrochloride, TRH122 low molecular weight sodium chondroitin sulfate and manganese ascorbate in the management of knee osteoarthritis.
Osteoarthritis Cartilage. 2000;8:343 - 350.
L'Hirondel JL. Double-blind clinical study with oral administration of chondroitin sulphate versus placebo in tibiofemoral gonarthrosis (125 patients) [in German].
Litera Rheumatol.
1992;14:77 - 84.
Morreale P, Manopulo R, Galati M, et al. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis.
J Rheumatol.
1996;23:1385 - 1391.
Nakazawa K. Effect of chondroitin sulfates on atherosclerosis. I. Long term oral administration of chondroitin sulfates to atherosclerotic subjects [in Japanese].
Nippon Naika Gakkai Zasshi.
1970;59:1084 - 1092.
Nakazawa K, Murata K. Comparative study of the effects of chondroitin sulfate isomers on atherosclerotic subjects.
ZFA.
1979;34:153 - 159.
Conte A, Volpi N, Palmieri L, et al. Biochemical and pharmacokinetic aspects of oral treatment with chondroitin sulfate.
Arzneimittelforschung.
1995;45:918 - 925.
Nguyen P, Mohamed SE, Gardiner D, et al. A randomized double-blind clinical trial of the effect of chondroitin sulfate and glucosamine hydrochloride on temporomandibular joint disorders: a pilot study.
Cranio.
2001;19:130 - 139.
Cohen M, Wolfe R, Mai T, et al. A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee.
J Rheumatol.
2003;30:523 - 528.
Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.
Osteoarthritis Cartilage. 1998;6(suppl A):37 - 38.
Uebelhart D, Thonar EJ, Zhang J, et al. Protective effect of exogenous chondroitin 4, 6-sulfate in the acute degradation of articular cartilage in the rabbit.
Osteoarthritis Cartilage. 1998;6(suppl A):6 - 13.
Ronca F, Palmieri L, Panicucci P, et al. Anti-inflammatory activity of chondroitin sulfate.
Osteoarthritis Cartilage. 1998;6(suppl A):14 - 21.
Hungerford DS. Treating osteoarthritis with chondroprotective agents.
Orthopedic Special Edition.
1998;4:39 - 42.
Tallia AF, Cardone DA. Asthma exacerbation associated with glucosamine-chondroitin supplement.
J Am Board Fam Pract.
2002;15:481 - 484.
Abdel Fattah W, Hammad T. Chondroitin sulfate and glucosamine: A review of their safety profile.
JANA. 2001;3:16-23.
Uebelhart D, Thonar EJ, Delmas PD, et al. Effects of oral chondroitin sulfate on the progression of knee osteoarthritis: a pilot study.
Osteoarthritis Cartilage. 1998;6(suppl A):39 - 46.
Verbruggen G, Goemaere S, Veys EM. Chondroitin sulfate: S/DMOAD (structure/disease modifying anti-osteoarthritis drug) in the treatment of finger joint OA.
Osteoarthritis Cartilage. 1998;6(suppl A):37 - 38.
Conrozier T. Anti-arthrosis treatments: efficacy and tolerance of chondroitin sulfates (CS 4&6) [translated from French].
Presse Med.
1998;27:1862 - 1865.
Uebelhart D, Thonar EJ, Zhang J, et al. Protective effect of exogenous chondroitin 4, 6-sulfate in the acute degradation of articular cartilage in the rabbit.
Osteoarthritis Cartilage. 1998;6(suppl A):6 - 13.
Uebelhart D, Thonar EJ, Zhang J, et al. Protective effect of exogenous chondroitin 4, 6-sulfate in the acute degradation of articular cartilage in the rabbit.
Osteoarthritis Cartilage. 1998;6(suppl A):6 - 13.
Ronca F, Palmieri L, Panicucci P, et al. Anti-inflammatory activity of chondroitin sulfate.
Osteoarthritis Cartilage. 1998;6(suppl A):14 - 21.
Hungerford DS. Treating osteoarthritis with chondroprotective agents.
Orthopedic Special Edition.
1998;4:39 - 42.
Ronca F, Palmieri L, Panicucci P, et al. Anti-inflammatory activity of chondroitin sulfate.
Osteoarthritis Cartilage. 1998;6(suppl A):14 - 21.
Abdel Fattah W, Hammad T. Chondroitin sulfate and glucosamine: A review of their safety profile.
JANA
2001;3:16-23.
La información aquí suministrada complementa la atención recibida por su médico. De ninguna forma intenta sustituir el consejo de un professional medico. LLAME A SU MEDICO DE INMEDIATO SI PIENSA QUE PODRIA TENER UNA EMERGENCIA. Siempre busque consejo médico antes de comenzar un nuevo tratamiento o si tiene preguntas sobre una condición médica.